Bruce Turner
Corporate Officer/Principal at IMMUNOME, INC.
Net worth: 631 962 $ as of 2024-05-30
Network origin in Bruce Turner first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Boxer Capital LLC
 Boxer Capital LLC Investment ManagersFinance Boxer Capital LLC (Boxer Capital) is a venture capital subsidiary of Tavistock Group, Inc. founded in 2005 by Chris Fuglesang and Aaron I. Davis. The firm is headquartered in San Diego, California.
5
| Subsidiary | Investment Managers | 5 |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.
3
| Subsidiary | Biotechnology | 3 |
Xanadu Bio Inc.
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bruce Turner via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oscar Gruss & Son, Inc.
 Oscar Gruss & Son, Inc. Investment Banks/BrokersFinance Founded in 1947 by Oscar Gruss and Emanuel Gruss, Oscar Gruss & Son, Inc. is a full-service broker/dealer located in New York City. The firm offers focused independent research and trading and execution services focusing particularly on special situations and convertibles. They conduct business with major Israeli institutional clients who execute trades in U.S. equities and options. Oscar Gruss & Son also maintains a trading desk in New York solely dedicated to European investors. The firm is a member of the NYSE and the SIPC. | Investment Banks/Brokers | Founder Founder | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| THE ONE GROUP HOSPITALITY, INC. | Restaurants | Chairman Director/Board Member | |
Brand & Services Acquisition Corp.
 Brand & Services Acquisition Corp. MiscellaneousMiscellaneous Brand & Services Acquisition Corp. operates as a blank check company. The company does not have any specific business combination under consideration or contemplation. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on February 14, 2007 and is headquartered in Ft. Lauderdale, FL. | Miscellaneous | Chairman Director/Board Member | |
| ZYNERBA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO President | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Plastron Acquisition Corp. IV
 Plastron Acquisition Corp. IV Financial ConglomeratesFinance Plastron Acquisition Corp. IV operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on June 22, 2011 and is headquartered in New York, NY. | Financial Conglomerates | President Director/Board Member | |
Plastron Acquisition Corp. III
 Plastron Acquisition Corp. III Financial ConglomeratesFinance Plastron Acquisition Corp. III operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on May 24, 2011 and is headquartered in New York, NY. | Financial Conglomerates | President Director/Board Member | |
| COMMITTED CAPITAL ACQUISITION CORPORATION II | Financial Conglomerates | Chief Executive Officer Founder | |
Committed Capital Acquisition Corp. III
 Committed Capital Acquisition Corp. III MiscellaneousMiscellaneous Committed Capital Acquisition Corp. III operates as a development stage company. The firm was organized for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, exchangeable stock transaction or other similar business transaction. The company was founded by Michael Rapoport and Philip R. Wagenheim on May 18, 2011 and is headquartered in New York, NY. | Miscellaneous | Chief Executive Officer Founder | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Boston College | College/University | Undergraduate Degree Director/Board Member | |
| Louisiana State University | College/University | Corporate Officer/Principal Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree Undergraduate Degree | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree | |
| Andhra University | College/University | Undergraduate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Chairman | |
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Just Another Acquisition Corp.
 Just Another Acquisition Corp. Financial ConglomeratesFinance Just Another Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Rocket Global Acquisition Corp.
 Rocket Global Acquisition Corp. Financial ConglomeratesFinance Rocket Global Acquisition Corp. operates as a blank check company. The firm was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated on February 9, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Hydrobuilder Holdings LLC
 Hydrobuilder Holdings LLC Internet Software/ServicesTechnology Services Hydrobuilder Holdings LLC is a leading omnichannel platform in the hydroponics, CEA, and specialty agriculture industry. The private company is based in the United States, with a retail footprint in four states and commercial warehouse direct capabilities in 17 states. The American company serves a wide range of customers, from hobbyists to large commercial growers, through its online, retail, and warehouse direct channels. These companies include Greencoast, Hydrobuilder.com, Elevated Equipment and Supply, and Way to Grow. Hydrobuilder Holdings was founded in October 2020 and has acquired four market-leading companies across different sales channels and geographies. The CEO of Hydrobuilder Holdings is Markus Alan Hockenson. | Internet Software/Services | Director/Board Member Director/Board Member Director/Board Member | |
| Paleo Pet Raw LLC | Chief Executive Officer | ||
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 47 |
| India | 3 |
| China | 2 |
| Italy | 2 |
Sectoral
| Health Technology | 18 |
| Finance | 14 |
| Consumer Services | 13 |
| Miscellaneous | 3 |
| Technology Services | 3 |
Operational
| Director/Board Member | 196 |
| Independent Dir/Board Member | 70 |
| Corporate Officer/Principal | 66 |
| President | 33 |
| Undergraduate Degree | 32 |
Most connected contacts
| Insiders | |
|---|---|
| Stephen P. Squinto | 40 |
| Peter Thompson | 39 |
| Jean-Jacques Bienaimé | 22 |
| Philip Wagenheim | 21 |
| Rapp Rapoport | 20 |
| John LaMattina | 20 |
| Clay Siegall | 18 |
| Julie Hambleton | 15 |
| James Avery | 15 |
| Todd Wider | 15 |
| Isaac Barchas | 14 |
| Gary Sender | 14 |
| Bradley Campbell | 13 |
| Carol Schafer | 13 |
| Richard Baron | 13 |
- Stock Market
- Insiders
- Bruce Turner
- Company connections
